Related references
Note: Only part of the references are listed.Radioiodine Ablation of Postsurgical Thyroid Remnants After Treatment With Recombinant Human TSH (rhTSH) in Patients With Moderate-to-Severe Graves' Orbitopathy (GO): A Prospective, Randomized, Single-Bind Clinical Trial
Mariacarla Moleti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinical Relevance of Thyroid-Stimulating Autoantibodies in Pediatric Graves' Disease-A Multicenter Study
T. Diana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Glucocorticoid Regimens for Prevention of Graves' Ophthalmopathy Progression Following Radioiodine Treatment: Systematic Review and Meta-Analysis
Shachaf Shiber et al.
THYROID (2014)
Extrathyroidal manifestations of Graves' disease: a 2014 update
Luigi Bartalena et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Analytical Performance and Clinical Utility of a Bioassay for Thyroid-Stimulating Immunoglobulins
Johannes J. Leschik et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center
M. L. Tanda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Clinical Utility of TSH Receptor Antibodies
Giuseppe Barbesino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Diagnosis and management of Graves disease: a global overview
Luigi Bartalena
NATURE REVIEWS ENDOCRINOLOGY (2013)
TSH receptor autoantibody immunoassay in patients with Graves' disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis
R. Tozzoli et al.
AUTOIMMUNITY REVIEWS (2012)
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
Leslie De Groot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease
Henry B. Burch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy
Luigi Bartalena
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
Rebecca S. Bahn et al.
THYROID (2011)
Outcome of Very Long-Term Treatment with Antithyroid Drugs in Graves' Hyperthyroidism Associated with Graves' Orbitopathy
Laura Elbers et al.
THYROID (2011)
The American Thyroid Association and American Association of Clinical Endocrinologists Hyperthyroidism and Other Causes of Thyrotoxicosis Guidelines: Viewpoints from Japan and Korea
Shunichi Yamashita et al.
THYROID (2011)
The American Thyroid Association/American Association of Clinical Endocrinologists Guidelines for Hyperthyroidism and Other Causes of Thyrotoxicosis: A European Perspective
George J. Kahaly et al.
THYROID (2011)
Sustained Control of Graves' Hyperthyroidism During Long-Term Low-Dose Antithyroid Drug Therapy of Patients with Severe Graves' Orbitopathy
Peter Laurberg et al.
THYROID (2011)
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
Alex Stagnaro-Green et al.
THYROID (2011)
Bioassays for TSH-receptor autoantibodies: An update
Simon D. Lytton et al.
AUTOIMMUNITY REVIEWS (2010)
Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins
S. D. Lytton et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Shifts in Propylthiouracil and Methimazole Prescribing Practices: Antithyroid Drug Use in the United States from 1991 to 2008
Ana B. Emiliano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Lower Dose Prednisone Prevents Radioiodine-Associated Exacerbation of Initially Mild or Absent Graves' Orbitopathy: A Retrospective Cohort Study
Adriana Lai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A Novel Bioreporter Assay for Thyrotropin Receptor Antibodies Using a Chimeric Thyrotropin Receptor (Mc4) Is More Useful in Differentiation of Graves' Disease from Painless Thyroiditis Than Conventional Thyrotropin-Stimulating Antibody Assay Using Porcine Thyroid Cells
Keiichi Kamijo et al.
THYROID (2010)
Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial
Matthias Schott et al.
CLINICAL ENDOCRINOLOGY (2009)
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Luigi Bartalena et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
The role of imaging in Graves' disease: A cost-effectiveness analysis
C. Cappelli et al.
EUROPEAN JOURNAL OF RADIOLOGY (2008)
Graves' disease
Gregory A. Brent
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Techniques to quantify TSH receptor antibodies
R. A. Ajjan et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids
Francesca Menconi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy
BS Prabhakar et al.
ENDOCRINE REVIEWS (2003)
Share Paper
